Concepedia
Statistics
Publications
12
Citations
715
H-Index
11
Active since
2002
Affiliations
The University of Texas MD Anderson Cancer Center(Current)
Baylor College of Medicine
Yonsei University
University of Michigan
Molecular Oncology (United States)
Feng Meng is an author at The University of Texas MD Anderson Cancer Center specializing in oncology, medicine, and pharmacology.
Publications per year
2002–2023
An Improved Patient-Derived Xenograft Humanized Mouse Model for Evaluation of Lung Cancer Immune Responses
Ismail M. Meraz, Mourad Majidi, Feng Meng et al. · Cancer Immunology Research · 2019 · 168 citations · Full text
Medicine, Immunology, Oncology +17
Association Between Imatinib-Resistant BCR-ABL Mutation-Negative Leukemia and Persistent Activation of LYN Kinase
Ji Yuan Wu, Feng Meng, Ling-Yuan Kong et al. · JNCI Journal of the National Cancer Institute · 2008 · 165 citations · Full text
Medicine, Oncology, Pharmacology +14
Lyn regulates BCR-ABL and Gab2 tyrosine phosphorylation and c-Cbl protein stability in imatinib-resistant chronic myelogenous leukemia cells
Ji Yuan Wu, Feng Meng, Henry Y. Lu et al. · Blood · 2008 · 109 citations · Full text
Medicine, Cell Biology, Oncology +9
Effective therapy of metastatic ovarian cancer with an oncolytic herpes simplex virus incorporating two membrane fusion mechanisms.
Mikihito Nakamori, Xinping Fu, Feng Meng et al. · PubMed · 2003 · 59 citations
Life Sciences, Molecular Biology, Oncology +17
Mechanism of Resveratrol-mediated Suppression of Tissue Factor Gene Expression
Usha R. Pendurthi, Feng Meng, Nigel Mackman et al. · Thrombosis and Haemostasis · 2002 · 41 citations
Veterinary Medicine, Pathobiology, Pharmacology +12
1–5 of 12